Rahsaan Thompson sold $438K of ZVRA stock

Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc. (ZVRA), sold 34,557 shares of ZVRA stock worth $438K, per an SEC Form 4 filed Jun 23, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 21, 2026, 2 days before it was made public.

ZVRA has moved -13.5% since the trade date, from $12.90 to $11.16 (Nov 12, 2026 close).